,

No evidence of benefit for chloroquine and hydroxychloroquine in COVID-19 patients

No evidence of benefit for chloroquine and hydroxychloroquine in COVID-19 - کلروکین و هیدروکسی کلروکین در درمان کرونا

A large observational study suggests that treatment with the antimalarial drug chloroquine or its analogue hydroxychloroquine (taken with or without the antibiotics azithromycin or clarithromycin) offers no benefit for patients with COVID-19. The study analyzed data from nearly 15,000 patients with COVID-19 receiving a combination of any of the four drug regimens and 81,000 controls.

Release date: 22 May 2020

Source: The Lancet

You might also like
Bark of Neem Tree May Protect Against Coronavirus Variants - اثرات ضدکرونایی پوست درخت چریش Bark of Neem Tree May Protect Against Coronavirus Variants
Gut microbiome and ALS - میکروب های روده Gut microbiome influences ALS outcomes
COVID 19 patients can be categorized into three groups Phenotypes - انواع سه گانه ابتلا به کووید19 COVID-19 patients can be categorized into three groups Phenotypes I, II and III
COVID19 in our dust may help predict outbreaks - حضور ویروس کرونا در گرد و خاک COVID-19 in our dust may help predict outbreaks
COVID Has Likely Tripled Depression Rates in the US - همه گیری کرونا شیوع علایم افسردگی را سه برابر کرده است COVID-19 Has Likely Tripled Depression Rates in the US
Among COVID19 survivors an increased risk of death serious illness - خطرات درازمدت کرونا Among COVID-19 survivors, an increased risk of death, serious illness